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Abstract 
A crucial public health problem in developing country like Bangladesh is resistance of antibiotics to different 
types of bacteria and the rates of these bacterial resistances are changing for various antibiotic therapy. Our aim 
was to assess the susceptible pattern of Levofloxacin a 3rd generation Quinolone antibiotic against uropathogens. 
A total of 12943 urine samples were collected in 2016 (Jan-Dec) and out of which 1236 (9.55%) were 
bacteriologically positive. Among the isolated uropathogens, 95.1% were gram negative and 4.9% gram positive 
organism. Male were found more prone to get UTI under 10 years and between 51-90 years of age and female 
were more affected in 10 to 50 years and over 90 years of age group. E. coli was the most prevalent (83.9%) 
isolate followed by Klebsiella spp. (6.7%), Staphylococcus aureus (2.6%), Pseudomonas spp. (2.2%), 
Enterococcus spp. (2.0%) and Proteus spp. (1.1%). The most predominant Levofloxacin sensitive organisms 
were found in male Enterobacter spp. (100%) and in female patients Serretia spp. (100%), Citrobacter spp. 
(100%) and Streptococcus Group B (100%). On the other hand the most predominant Levofloxacin resistant 
organisms were found in male and female both Acinetobacter spp. (100%). Around (61.7%) male and (46.9%) 
female were found resistant to E. coli. 
Keywords: Levofloxacin, Quinolone, UTI, Resistance, Uropathogen. 
 
1. Introduction 
Antibiotic resistance is an increasing threat to life and morbidity and mortality. Urinary Tract Infection (UTI) is 
a predominant infection all over the world but it is more prevalent in developing south Asian countries like 
Bangladesh. Urinary Tract Infection (UTI) represents as one of the most common diseases encountered in 
medical practices these days and encompasses a broad range of clinical fields that are associated with a common 
finding of positive urine cultures. Besides every year about 150 million people are affected by UTIs. Worldwide 
at a cost of about US$6 billion and even UTIs have demonstrated significant morbidity and mortality (1).  
They are the second most common types of infection in humans accounting for 8.3 million doctor’s visit 
annually in USA (2). UTI can be nosocomially ubiquitous in clinical environment so that prevalence rate of 
uropathogens is being alarmingly accelerated (1). Urinary tract infection is more common in female than male, 
because of the short length of the urethra and its proximity to anus. Pregnancy and sexual activity also make 
female more susceptible to UTI. Different factors like age, sex, immunosuppression and urological instruments 
may affect prevalence of UTIs (3).  
The early introduction of effective drugs against bacterial infections in the last century has changed the 
medical behavior and has significantly reduced the mortality rates due to these agents. Also, the widespread use 
of antibiotics has induced different mechanisms of bacteria resistance to these drugs (4). Bacterial resistance is 
naturally developed, being a consequence of bacteria adaptation to the environment. The exposure of 
microorganisms to different antibiotics increases the selective pressure and favors the development of resistance 
(5). The etiology of UTIs and the antibiotic susceptibility of urinary pathogens, both in community and hospitals, 
have been changing over the past years and recently, the antibiotic resistance has become a major global problem 
(6). A large proportion of uncontrolled antibiotic usage has contributed to the emergence of resistant bacterial 
infections (7). 
However, Levofloxacin is an antibiotic that used to treat a number of bacterial infections including acute 
bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis and some types of gastroenteritis. It is 
available by mouth, intravenously and in eye drop form (8, 9). Levofloxacin was approved for medical use in the 
United States in 1996 (8). It is on the World Health Organization's List of Essential Medicines, the most 
effective and safe medicines needed in a health system (10). It is available as a generic medication (8). 
In addition, Levofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-
negative bacteria. Like all quinolones, it functions by inhibiting the DNA gyrase and topoisomerase IV (11). 
Topoisomerase IV is necessary to separate DNA that has been replicated (doubled) prior to bacterial cell 
division. With the DNA not being separated, the process is stopped, and the bacterium cannot divide. DNA 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.8, No.4, 2018 
 
75 
gyrase, on the other hand, is responsible for super coiling the DNA, so that it will fit in the newly formed cells. 
Both mechanisms amount to killing the bacterium. Levofloxacin acts as a bactericide (12).  
It is the most effective drugs for UTI patients in Bangladesh for treatment of UTI patients. But now a days 
we see the drugs does not work against uropathogens as before works. Our aim of the study to see the state of 
susceptibility pattern of Levofloxacin against Urinary Tract Infection patients in selected areas (Badda, Gulshan, 
Baridhara, Rampura, Doyagonj, Gandaria, Jatrabari, Sayedabad, Dhaka, Bangladesh). 
 
2. Materials and methods 
Materials  
Study Design:  
Study Location: This was a retrospective analysis of laboratory data routinely collected from the microbiology 
department of IBN SINA Diagnostic & Consultation Center, Badda, Dhaka-1212, Bangladesh fromt January 1, 
2016 to December 31, 2016. The total sample volumes were 12943. 
Methods 
Sample Collection and Bacteriological Assessment: Early morning midstream urine samples were collected 
aseptically from 12943 (Male-3638 & female-9305) patients. The urine samples were collected into sterile wide 
container (China) with screw cap tops. On the label were the name, age, sex and time of collection. All the 
patients were instructed on how to collect the urine samples aseptically and taken to the laboratory immediately 
for culture. In the diagnostic laboratory, each well mixed urine sample (1µL) was inoculated on MacConkey agar 
(Oxoid) and Blood agar (Oxoid) media plate under class-II laminar airflow (NUVO Sanaji Malzemelzeni, Imalat 
Vc Ticaret A.S, Turkey). The inoculum on the plate was streaked out for discrete colonies with a sterile wire 
loop sterilized by auto loop sterilizer (Germany) following standard procedures.  The culture plates were 
incubated at 37°C by an incubator (Germany) for 48 hours and observed for the growth of bacteria through 
formation of colonies. All the bacteria were isolated and identified using morphological, microscopy (Japan) and 
biochemical tests like TSI (HiMedia), MIU (HiMedia) and Simmons Citrate (HiMedia) agar following standard 
procedures.(13) 
Antibiotic Susceptibility Assessment: The disc diffusion technique was used for antibacterial susceptibility 
testing of the isolates using commercial antibiotics containing discs. We used the commercial antibiotic disc 
Levofloxacin (5µg, Oxoid). Interpretation of results was done using zone sizes. Zones of inhibition for 
Enterobacteriaceae, P. aeruginosa, S. maltophilia, Acinetobacter spp., Enterococcus spp., Streptococcus spp., 
Viridans Group, ß-Hemolytic Group and S. pneumoniae ≥17 mm was considered sensitive, 14-16 mm 
intermediate and ≤13 mm resistant, for Staphylococcus spp. ≥19 mm was considered sensitive, 16-18 mm 
intermediate and ≤15 mm resistant. and for Haemophilus spp. ≥17 mm was considered sensitive . Isolates were 
classified as either sensitive or resistant based on the definition of the Clinical and Laboratory Standard 
Institute.(14) Some laboratory stains of known sensitivity of Staphylococcus aureus ATCC 29213, Enterococcus 
faecalis ATCC 29212, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and 
Streptococcus pneumoniae ATCC 49619 were used as quality control strains for the antimicrobial discs. 
Statistical Analysis: Data were assessed using the Statistical Package for Social Science (IBM SPSS 
Statistics, version 18, IBM Corporation, SPSS Inc. Chicago, III, USA). The Trend chi square test for statistical 
comparisons between the groups.   
 
3. Results 
The total 12943 urine samples collected from patients, 1236 (9.55%) samples were positive and 11707 (90.45%) 
samples were negative at 2016 (January-December) in selected areas (Badda, Gulshan, Baridhara, Rampura, 
Doyagonj, Gandaria,Jatrabari, Sayedabad, Dhaka, Bangladesh). 
Tabel-1: Distribution table of Urinary Tract Infection (UTI) patients by age groups and gender (n=1236) 
Age (Years) <10 11-20 21-30 31-40 41-50 51-60 61-70 71-80 81-90 >90 
Male 53 05 19 16 26 38 73 38 05 02 
Female 103 83 181 113 149 130 124 56 14 08 
Total 156 88 200 129 175 168 197 94 19 10 
           
In our study, table-1 showed the distribution table of urinary tract infection affected patients by their age groups 
and gender. The highest of the study subjects under goes to the 21-30 years age group (200 patients=181 female 
+ 19 male) and followed by 61-70 years age group (197 patients=124 female + 73 male), 41-50 years age group 
(175 patients=149 female + 26 male), 51-60 years age group (168 patients= 130 female + 38 male) and <10 
years age group (156 patients= 103 female+ 53 male) respectively.  Most prevalent frequency of female and 
male patients affected by uropathogens was found in 21-30 years and 61-70 years age group respectively.  
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Figure-1: UTI percentage among different age groups of male (N=275) and female (N=961) 
The percentage of male patients were more porne besides female patients (19.3% > 10.7%) under 10 years 
age groups.   In between 11-20, 21-30, 31-40 and 41-50 years of age group female UTI infection (8.6%, 18.8%, 
11.8% and 15.5% respectively) is higher than male (1.8%, 6.9%, 5.8% and 9.5% respectively).  In between 51-
60, 61-70 , 71-80 and 81-90 years age male infection (13.8%, 26.5%, 13.8% and 1.8% respectively) is higher 
than female (13.5%, 12.9%, 5.8 % and 1.5% respectively). Above 90 years age female infection (0.8%) is higher 
than male (0.7%) but here number of patients were very few.  
Table-2: Distribution of specific uropathogen mediated UTI among UTI patients 
Organisms Percentage (n=1236) 
Male Female Total 
E. coli 222(18.0%) 815(65.9%) 1037(83.9%) 
Klebsiella spp. 17(1.4%) 66(5.3%) 83(6.7%) 
Staphylococcus aureus 5(0.4%) 27(2.2%) 32(2.6%) 
Pseudomonas spp. 15(1.2%) 12(1.0%) 27(2.2%) 
Enterococcus spp. 8(0.6%) 17(1.4%) 25(2.0%) 
Proteus spp. 6(0.5%) 8(0.6%) 14(1.1%) 
Enterobacter spp. 1(0.1%) 9(0.7%) 10(0.8%) 
Acinetobacter spp. 1(0.1%) 1(0.1%) 2(0.2%) 
Serretia spp. 0(0.0%) 2(0.2%) 2(0.2%) 
Staphylococcus saprophyticus 0(0.0%) 2(0.2%) 2(0.2%) 
Citrobacter spp. 0(0.0%) 1(0.1%) 1(0.1%) 
Streptococcus Group B 0(0.0%) 1(0.1%) 1(0.1%) 
Total 275 (22.2%) 961 (77.8%) 1236 (100.0%) 
    
Table-2 showed that the most predominant organism E. coli 1037(male 222 and female 815) found in UTI 
patients. According to number or percentage distribution, the second prevalent organism was Klebsiella spp. 83 
(male 17 & female 66) followed by Staphylococcus aureus 32 (male 5 and female 27), Pseudomonas spp. 27 
(male 15 and female 12), Enterococcus spp. 25 (male 8 and female 17), Proteus spp. 14 (male 6 and female 8) 
and Enterobacter spp. 10 (male 1 and female 9) respectively. In total bacteriologically positive cases, the most 
prone organism in male and female were E. coli (18.0% and 65.9 %) respectively. Moreover, all the isolated 
organisms were found highest in female except Pseudomonas spp. in contrast male patients. On the other hand 
the study showed that the total 22.2% male patients and 77.8% female patients were found.  
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Table-3: Prevalence of different uropathogens among male and female patients 
Organisms 
Male (n=275) Female (n=961) 
Number Percentage Number Percentage 
E. coli 222 80.7% 815 84.8% 
Klebsiella spp. 17 6.2% 66 6.9% 
Staphylococcus aureus 5 1.8% 27 2.8% 
Pseudomonas spp 15 5.5% 12 1.2% 
Enterococcus spp. 8 2.9% 17 1.8% 
Enterobacter spp. 1 0.4% 9 0.9% 
Proteus spp. 6 2.2% 8 0.8% 
Serretia spp. 0 0.0% 2 0.2% 
Staphylococcus saprophyticus 0 0.0% 2 0.2% 
Acinetobacter spp. 1 0.4% 1 0.1% 
Citrobacter spp. 0 0.0% 1 0.1% 
Streptococcus Group B 0 0.0% 1 0.1% 
Total 275 100.0% 961 100.0% 
     
In this study, the urinary tract infections of female patients (961) were more prone to male patients 
(275). In male, the most predominant uropathogen were E.coli (80.7%) followed by Klebsiella spp. (6.2%), 
Pseudomonas spp. (5.5%), Enterococcus spp. (2.9%), Staphylococcus aureus (1.8%). In female, the most 
prevalent uropathogen were E. coli (84.8%) followed by Klebsiella spp. (6.9%), Staphylococcus aureus (2.8%), 
Enterococcus spp. (1.8%),   Pseudomonas spp. (1.2%). The study noted that female patients were more infected 
by all of the isolated organism (E. coli, Klebsiella spp., Staphylococcus aureus, Enterobacter spp., Serretia spp., 
Staphylococcus saprophyticus, Citrobacter spp. and Streptococcus Group B) except some organisms 
(Pseudomonas spp. and Enterococcus spp., Proteus spp. and Acinetobacter spp.) but here the number were very 
few.  
Table-4: Susceptibility pattern of Levofloxacin against uropathogens among male UTI patients (n=275) 
Name of organisms 
Sensitive Resistant 
Number Percentage Number Percentage 
E. coli 85 38.3% 137 61.7% 
Proteus spp. 4 66.7% 2 33.3% 
Pseudomonas spp. 6 40.0% 9 60.0% 
Klebsiella spp. 7 41.2% 10 58.8% 
Enterobacter spp. 1 100.0% 0 0.0% 
Staphylococcus aureus 3 60.0% 2 40.0% 
Enterococcus spp. 5 62.5% 3 37.5% 
Acinetobacter spp. 0 0.0% 1 100.0% 
Total 111 40.4% 164 59.6% 
     
Table-4 showed that Levofloxacin sensitive against isolated uropathogenic bacteria in total male patients 
were 40.4% and rest of resistant 59.6%. All of them (100%) Enterobacter spp. was sensitive to Levofloxacin but 
here the numbers were very few. On the other hand the most prevalent resistant organism was Acinetobacter spp. 
(100%) here the numbers were very few also. In contrast of frequency, E.coli was the most significant organism 
which was 38.3 % sensitive and 61.7 % resistant to Levofloxacin. However, the other isolated bacteria’s 
sensitive pattern to Levofloxacin followed by Proteus spp.(66.7%), Pseudomonas spp. (40.0%), Klebsiella spp. 
(41.2%), Staphylococcus aureus (60.0%) and Enterococcus spp. (62.5%) and resistant pattern followed by 
Proteus spp.(33.3%), Pseudomonas spp. (60.0%), Klebsiella spp. (58.8%), Staphylococcus aureus (40.0%) and 
Enterococcus spp. (37.5%) respectively.  
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Table-5: Susceptibility pattern of Levofloxacin against uropathogens among female UTI patients (n=961) 
Name of organisms 
Sensitive Resistant 
Number Percentage Number Percentage 
E. coli 433 53.1% 382 46.9% 
Proteus spp. 4 50.0% 4 50.0% 
Pseudomonas spp. 7 58.3% 5 41.7% 
Klebsiella spp. 43 65.2% 23 34.8% 
Enterobacter spp. 8 88.9% 1 11.1% 
Staphylococcus aureus 15 55.6% 12 44.4% 
Enterococcus spp. 9 52.9% 8 47.1% 
Acinetobacter spp. 0 0.0% 1 100.0% 
Citrobacter spp. 1 100.0% 0 0.0% 
Streptococcus Group B 1 100.0% 0 0.0% 
Serretia spp. 2 100.0% 0 0.0% 
Staphylococcus saprophyticus 1 50.0% 1 50.0% 
Total 524 54.5% 437 45.5% 
     
In our study table-5 showed that Levofloxacin sensitive against isolated uropathogenic bacteria in total 
female patients were 54.5% and rest of resistant 45.5%. All of them (100%) Serretia spp., Citrobacter spp. and 
Streptococcus Group B were sensitive to Levofloxacin but here the numbers were very few. On the other hand 
the most prevalent resistant organism was Acinetobacter spp. (100%) but here the numbers were very few also. 
By contrast of frequency, E.coli was the most significant organism which was 53.1 % sensitive and 46.9 % 
resistant to Levofloxacin. However, the other isolated bacteria’s sensitive pattern to Levofloxacin followed by 
Proteus spp.(50.0%), Pseudomonas spp. (58.3%), Klebsiella spp. (65.2%), Enterobacter spp. (88.9%), 
Staphylococcus aureus (55.6%), Enterococcus spp. (52.9%) and Staphylococcus saprophyticus (50.0%) and 
resistant pattern followed by Proteus spp.(50.0%), Pseudomonas spp. (41.7%), Klebsiella spp. (34.8%), 
Enterobacter spp. (11.1%), Staphylococcus aureus (44.4%), Enterococcus spp. (47.1%) and Staphylococcus 
saprophyticus (50.0%) respectively.  
 
4. Discussion 
For misuse or abuse of antibiotics, followed by an increase in the bacterial resistance rates, this study aimed to 
evaluate the pattern of antimicrobial susceptibility of bacteria isolated from patients with UTI seen at the IBN 
SINA diagnostic center, Badda, Dhaka, Bangladesh. Moreover, we have identified the crucial bacterial species 
associated with UTI and described the profile of resistance to Levofloxacin. It is important that clinicians are 
aware of the regional antibiotic resistance rates before initiating experimental antimicrobial therapy for UTI 
treatment, as it is well-described that urinary infection with a resistant pathogen is more likely to lead to 
bacteriological/clinical failures (15). In our study, we tested total 12943 urine samples and 1236 (9.55%) were 
bacteriological positive and 11707 (90.45%) were bacteriological negative found.  
In our study we found The highest of the study subjects under goes to the 21-30 years age group (200 
patients=181 female + 19 male) and followed by 61-70 years age group (197 patients=124 female + 73 male), 
41-50 years age group (175 patients=149 female + 26 male), 51-60 years age group (168 patients= 130 female + 
38 male) and <10 years age group (156 patients= 103 female + 53 male) respectively. According to frequency in 
total infected patients, we saw that mostly female patients are affected by uropathogens in all the age groups in 
contrast male patients. It was noted that the highest frequency of UTIs observed in women when compared to 
men, which is often attributed to a shorter urethra that facilitates colonization by these microorganisms.(1) Most 
prevalent frequency of female and male patients affected by uropathogens was found in 21-30 years and 61-70 
years age group respectively. However, there were found significant difference between the age groups and sex 
of urinary tract infection patients at 5% (P<0.05).  
In the fugure we saw the percentage of male patients were more porne in contrast female patients (19.3% > 
10.7%) under 10 years age groups. Our finding is supported by the fact that uncircumcised male infants appear 
to be at increased risk of UTIs in the first three months of life. In a study of 100 otherwise healthy infants 
ranging in age from five days to eight months and admitted to the hospital because of a first known UTI. Most of 
the UTIs in infants younger than three months of age were in male, but female infants predominated thereafter 
(16). We also found in between 11-20, 21-30, 31-40 and 41-50 years of age group female UTI infection (8.6%, 
18.8%, 11.8% and 15.5% respectively) is higher than male (1.8%, 6.9%, 5.8% and 9.5% respectively).  In 
between 51-60, 61-70 , 71-80 and 81-90 years age male infection (13.8%, 26.5%, 13.8% and 1.8% respectively) 
is higher than female (13.5%, 12.9%, 5.8 % and 1.5% respectively). Above 90 years age female infection (0.8%) 
is higher than male (0.7%) but here number of patients were very few. The most predominat age gorup was 21-
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20 years in female patients. Incidence of infection in female increases directly with sexual activity and child-
bearing. In the women, 25-30% of women between 20-40 years of age will get UTIs. The anatomical 
relationship of the female urethra and the vagina makes it liable to trauma during sexual intercourse as well as 
bacteria been massaged up the urethra into the bladder during pregnancy and child birth.  It has been reported in 
several studies that women who are sexually active, and especially if they use contraceptives, foams, gels, 
diaphragm and spermicides which are known to promote greater colonization of the vagina are at higher risk of 
developing UTIs (1). Furthermore, another mechanism that could explain the lower frequency of UTI in men 
would be the prostatic fluid, which has antibacterial substances (17). We got 961 (77.8%) female and 275 
(22.2%) male patients. However, there were found significant difference between the percentage of age groups 
and sex of urinary tract infection patients at 5% (P<0.05). 
Table-2 showed that the most predominant organism E. coli 1037(male 222 and female 815) found in UTI 
patients. According to number or percentage distribution, the second prevalent organism was Klebsiella spp. 83 
(male 17 & female 66) followed by Staphylococcus aureus 32 (male 5 and female 27), Pseudomonas spp. 27 
(male 15 and female 12), Enterococcus spp. 25 (male 8 and female 17), Proteus spp. 14 (male 6 and female 8) 
and Enterobacter spp. 10 (male 1 and female 9) respectively. In total bacteriologically positive cases, the most 
prone organism in male and female were E. coli (18.0% and 65.9 %) respectively. There is fecal contamination 
of periurethral area, then the bacteria spreads on ascending through the bladder and causes cystitis. These 
infections of the lower urinary tract, in some cases, can affect the kidneys and cause acute pyelonephritis, which 
consequently may result in bacteremia and sepsis (18). Moreover, all the isolated organisms were found highest 
in female except Pseudomonas spp. in contrast male patients. On the other hand the study showed that the total 
22.2% male patients and 77.8% female patients were found. Moreover, there were found significant difference 
between the isolated organism and sex of urinary tract infection patients at 5% (P<0.05). 
In this study, the urinary tract infections of female patients (961) were more prone to male patients (275). In 
male, the most predominant uropathogens were E. coli (80.7%) followed by Klebsiella spp. (6.2%), 
Pseudomonas spp. (5.5%), Enterococcus spp. (2.9%), Staphylococcus aureus (1.8%). In female, the most 
prevalent uropathogen were E. coli (84.8%) followed by Klebsiella spp. (6.9%), Staphylococcus aureus (2.8%), 
Enterococcus spp. (1.8%),   Pseudomonas spp. (1.2%).. Several studies have shown that Escherichia coli is the 
major bacterial species associated with UTIs, and Klebsiella pneumoniae is the second most important bacteria 
in this type of infection (19). The study noted that female patients were more infected by all of the isolated 
organism (E. coli, Klebsiella spp.. Staphylococcus aureus, Enterobacter spp., Serretia spp., Staphylococcus 
saprophyticus, Citrobacter spp. and Streptococcus Group B) except some organisms (Pseudomonas spp. and 
Enterococcus spp., Proteus spp. and Acinetobacter spp.) but here the number were very few. However, there 
were found significant difference between the percentage and frequency of isolated organism and sex of urinary 
tract infection patients at 5% (P<0.05). 
Treatment of urinary tract infections is becoming more complicated with an increase of the number of 
resistant strains to antibiotics and prevalence of antibiotic resistance mechanisms. Table-4 showed that 
Levofloxacin sensitive against isolated uropathogenic bacteria in total male patients were 40.4% and rest of 
resistant 59.6%. All of them (100%) Enterobacter spp. was sensitive to Levofloxacin but here the numbers were 
very few. On the other hand the most prevalent resistant organism was Acinetobacter spp. (100%) here the 
numbers were very few also. In contrast of frequency, E. coli was the most significant organism which was 38.3 
% sensitive and 61.7 % resistant to Levofloxacin. However, the other isolated bacteria’s sensitive pattern to 
Levofloxacin followed by Proteus spp. (66.7%), Pseudomonas spp. (40.0%), Klebsiella spp. (41.2%), 
Staphylococcus aureus (60.0%) and Enterococcus spp. (62.5%) and resistant pattern followed by Proteus 
spp.(33.3%), Pseudomonas spp. (60.0%), Klebsiella spp. (58.8%), Staphylococcus aureus (40.0%) and 
Enterococcus spp. (37.5%) respectively. In our study also saw that the percentage of resistant of most of the 
organisms in male were higher than sensitive which is highly alarming message. There were no significant 
difference among the susceptibility pattern of Levofloxacin, isolated organism and sex of the patients at 5% 
(P>0.05). 
In our study Table-5 showed that Levofloxacin sensitive against isolated uropathogenic bacteria in total 
female patients were 54.5% and rest of resistant 45.5%. All of them (100%) Serretia spp., Citrobacter spp. and 
Streptococcus Group B were sensitive to Levofloxacin but here the numbers were very few. On the other hand 
the most prevalent resistant organism was Acinetobacter spp. (100%) but here the numbers were very few also. 
By contrast of frequency, E. coli was the most significant organism which was 53.1 % sensitive and 46.9 % 
resistant to Levofloxacin. However, the other isolated bacteria’s sensitive pattern to Levofloxacin followed by 
Proteus spp.(50.0%), Pseudomonas spp. (58.3%), Klebsiella spp. (65.2%), Enterobacter spp. (88.9%), 
Staphylococcus aureus (55.6%), Enterococcus spp. (52.9%) and Staphylococcus saprophyticus (50.0%) and 
resistant pattern followed by Proteus spp.(50.0%), Pseudomonas spp. (41.7%), Klebsiella spp. (34.8%), 
Enterobacter spp. (11.1%), Staphylococcus aureus (44.4%), Enterococcus spp. (47.1%) and Staphylococcus 
saprophyticus (50.0%) respectively. In our study also saw that the percentage of resistant of most of the 
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organisms in male were higher than sensitive which is highly alarming message. There were no significant 
difference among the susceptibility pattern of Levofloxacin, isolated organism and sex of the patients at 5% 
(P>0.05). 
The knowledge on the regional pattern of bacterial resistance is critical to guide the medical staff to choose 
an appropriate antibiotic for the treatment of UTI patients (20). Bacterial resistance has become a public health 
issue and has increasingly been associated with risk factors that put life in danger (1). Awareness is needed of 
both the population and health professionals about the importance for the correct use of antibiotics, and it is 
mandatory to take into account the result of antibiotics susceptibility tests. The Levofloxacin use should be 
performed only after the microbial susceptibility confirmation, and it is necessary to find other alternatives for 
the empirical treatment. The bacterial resistance prevention can be performed through control measures that limit 
the spread of resistant bacteria and the rational use of antimicrobial policy. 
 
5. Conclusion 
In conclusion, the results showed that there was a high prevalence of occurrence of urinary tract infection among 
patients of areas (Badda, Gulshan, Baridhara, Rampura, Doyagonj, Gandaria, Jatrabari, Sayedabad, Dhaka, 
Bangladesh). Most of the bacteria were resistant to Levofloxacin which is highly alarming message for human 
being. To prescribe Levofloxacin antibiotic should follow the antibiotic guidelines in order to prevent emergence 
of multi drug resistant organisms. 
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